Synovus Financial Corp Astrazeneca PLC Transaction History
Synovus Financial Corp
- $8.56 Billion
- Q3 2024
A detailed history of Synovus Financial Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Synovus Financial Corp holds 64,860 shares of AZN stock, worth $4.35 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
64,860
Previous 64,860
-0.0%
Holding current value
$4.35 Million
Previous $5.05 Million
-0.0%
% of portfolio
0.06%
Previous 0.05%
Shares
27 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.21 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.81 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...